vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Shimmick Corp (SHIM). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $141.9M, roughly 1.2× Shimmick Corp). Shimmick Corp runs the higher net margin — -3.1% vs -82.0%, a 78.9% gap on every dollar of revenue. Shimmick Corp produced more free cash flow last quarter ($-28.7M vs $-36.6M). Over the past eight quarters, Shimmick Corp's revenue compounded faster (-10.1% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Shimmick Corp is a U.S.-based heavy civil construction firm specializing in building and upgrading critical public infrastructure, including water facilities, transportation systems, dams, and environmental remediation projects. It primarily serves federal, state, and local government clients across North America, delivering complex large-scale construction solutions for public sector segments.

PTCT vs SHIM — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.2× larger
PTCT
$164.7M
$141.9M
SHIM
Higher net margin
SHIM
SHIM
78.9% more per $
SHIM
-3.1%
-82.0%
PTCT
More free cash flow
SHIM
SHIM
$7.9M more FCF
SHIM
$-28.7M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
SHIM
SHIM
Annualised
SHIM
-10.1%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PTCT
PTCT
SHIM
SHIM
Revenue
$164.7M
$141.9M
Net Profit
$-135.0M
$-4.4M
Gross Margin
7.6%
Operating Margin
-43.3%
-2.2%
Net Margin
-82.0%
-3.1%
Revenue YoY
-22.7%
Net Profit YoY
-104.8%
EPS (diluted)
$-1.63
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SHIM
SHIM
Q4 25
$164.7M
$141.9M
Q3 25
$211.0M
$128.4M
Q2 25
$178.9M
$122.1M
Q1 25
$1.2B
$103.6M
Q4 24
$213.2M
Q3 24
$196.8M
$166.0M
Q2 24
$186.7M
$90.6M
Q1 24
$210.1M
$120.0M
Net Profit
PTCT
PTCT
SHIM
SHIM
Q4 25
$-135.0M
$-4.4M
Q3 25
$15.9M
$-8.5M
Q2 25
$-64.8M
$-9.8M
Q1 25
$866.6M
$-38.5M
Q4 24
$-65.9M
Q3 24
$-106.7M
$-1.6M
Q2 24
$-99.2M
$-51.4M
Q1 24
$-91.6M
$-33.3M
Gross Margin
PTCT
PTCT
SHIM
SHIM
Q4 25
7.6%
Q3 25
6.3%
Q2 25
3.8%
Q1 25
-20.1%
Q4 24
Q3 24
7.3%
Q2 24
-34.4%
Q1 24
-13.2%
Operating Margin
PTCT
PTCT
SHIM
SHIM
Q4 25
-43.3%
-2.2%
Q3 25
1.4%
-5.5%
Q2 25
-19.5%
-7.3%
Q1 25
82.5%
-39.3%
Q4 24
-76.2%
Q3 24
-27.7%
0.7%
Q2 24
-21.5%
-53.0%
Q1 24
-21.6%
-26.5%
Net Margin
PTCT
PTCT
SHIM
SHIM
Q4 25
-82.0%
-3.1%
Q3 25
7.5%
-6.6%
Q2 25
-36.3%
-8.0%
Q1 25
73.7%
-37.1%
Q4 24
-30.9%
Q3 24
-54.2%
-0.9%
Q2 24
-53.1%
-56.7%
Q1 24
-43.6%
-27.8%
EPS (diluted)
PTCT
PTCT
SHIM
SHIM
Q4 25
$-1.63
$-0.12
Q3 25
$0.20
$-0.25
Q2 25
$-0.83
$-0.28
Q1 25
$10.04
$-0.92
Q4 24
$-0.85
Q3 24
$-1.39
$-0.05
Q2 24
$-1.29
$-1.83
Q1 24
$-1.20
$-1.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SHIM
SHIM
Cash + ST InvestmentsLiquidity on hand
$1.9B
$17.6M
Total DebtLower is stronger
$57.5M
Stockholders' EquityBook value
$-205.3M
$-52.7M
Total Assets
$2.9B
$218.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SHIM
SHIM
Q4 25
$1.9B
$17.6M
Q3 25
$1.7B
$21.4M
Q2 25
$2.0B
$16.3M
Q1 25
$2.0B
$33.7M
Q4 24
$1.1B
Q3 24
$1.0B
$26.0M
Q2 24
$1.1B
$22.4M
Q1 24
$884.8M
$27.3M
Total Debt
PTCT
PTCT
SHIM
SHIM
Q4 25
$57.5M
Q3 25
$36.4M
Q2 25
$31.4M
Q1 25
$9.5M
Q4 24
Q3 24
$39.9M
Q2 24
Q1 24
$31.5M
Stockholders' Equity
PTCT
PTCT
SHIM
SHIM
Q4 25
$-205.3M
$-52.7M
Q3 25
$-155.8M
$-49.5M
Q2 25
$-206.5M
$-42.6M
Q1 25
$-185.8M
$-34.7M
Q4 24
$-1.1B
Q3 24
$-1.1B
$973.0K
Q2 24
$-980.2M
$436.0K
Q1 24
$-893.9M
$38.1M
Total Assets
PTCT
PTCT
SHIM
SHIM
Q4 25
$2.9B
$218.5M
Q3 25
$2.6B
$203.0M
Q2 25
$2.6B
$227.7M
Q1 25
$2.7B
$233.9M
Q4 24
$1.7B
Q3 24
$1.8B
$346.7M
Q2 24
$1.9B
$344.5M
Q1 24
$1.8B
$378.0M
Debt / Equity
PTCT
PTCT
SHIM
SHIM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.01×
Q2 24
Q1 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SHIM
SHIM
Operating Cash FlowLast quarter
$-34.3M
$-23.7M
Free Cash FlowOCF − Capex
$-36.6M
$-28.7M
FCF MarginFCF / Revenue
-22.3%
-20.2%
Capex IntensityCapex / Revenue
1.4%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$-27.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SHIM
SHIM
Q4 25
$-34.3M
$-23.7M
Q3 25
$-66.3M
$-3.8M
Q2 25
$-58.3M
$-38.2M
Q1 25
$870.1M
$44.9M
Q4 24
$-30.0M
Q3 24
$-77.0M
$12.7M
Q2 24
$-71.5M
$-43.9M
Q1 24
$70.8M
$-35.0M
Free Cash Flow
PTCT
PTCT
SHIM
SHIM
Q4 25
$-36.6M
$-28.7M
Q3 25
$-69.7M
$-4.2M
Q2 25
$-59.6M
$-38.7M
Q1 25
$868.4M
$44.4M
Q4 24
$-33.8M
Q3 24
$-77.5M
$10.3M
Q2 24
$-78.8M
$-46.8M
Q1 24
$61.2M
$-39.6M
FCF Margin
PTCT
PTCT
SHIM
SHIM
Q4 25
-22.3%
-20.2%
Q3 25
-33.1%
-3.2%
Q2 25
-33.3%
-31.7%
Q1 25
73.8%
42.9%
Q4 24
-15.8%
Q3 24
-39.4%
6.2%
Q2 24
-42.2%
-51.7%
Q1 24
29.1%
-33.0%
Capex Intensity
PTCT
PTCT
SHIM
SHIM
Q4 25
1.4%
3.5%
Q3 25
1.6%
0.3%
Q2 25
0.7%
0.4%
Q1 25
0.1%
0.5%
Q4 24
1.8%
Q3 24
0.3%
1.4%
Q2 24
4.0%
3.3%
Q1 24
4.6%
3.8%
Cash Conversion
PTCT
PTCT
SHIM
SHIM
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

SHIM
SHIM

Shimmick Projects$106.8M75%
Non Core Projects$35.1M25%

Related Comparisons